PharmaLex Group, a leading provider of specialized services for the pharma, 
biotech and medtech industries worldwide, has announced the opening of a new 
branch in Beijing, China, giving global clients access to a team of regulatory 
experts in the region. 

As of September 2022, the newly established PharmaLex Beijing team, which 
includes personnel joining from Bayer China, will be offering the full 
PharmaLex value proposition for pharmacovigilance, regulatory affairs, 
development consulting and quality management to global clients bringing 
products to the China market. These offerings will make the office a center of 
expertise in this growing marketplace. PharmaLex China will also be the local 
contact point for Chinese-based biopharmaceutical companies that are developing 
pharmaceuticals or medical devices with a goal of entering the European or US 
markets.  

In addition, Pharmalex is preparing to open a second China office in Jinan, 
which will extend the local footprint and provide clients with further access 
to a regulatory talent pool in the country.
 
The China office will be led by Sophia Huang, Executive Director and Department 
Head, who leads operations and business development and is supported by a 
growing team, currently comprising 16 highly skilled regulatory submission and 
publishing experts.  

"We welcome the opportunity to become part of the PharmaLex family, where we 
can grow our services and reach with a company that has a strong focus on its 
people and that has a reputation for transparency and reliability," Ms. Huang 
said. "This is an exciting opportunity to continue to expand our skill set and 
reach."
 
"APAC, and China in particular, is a strategic focus region for the 
pharmaceutical industry, both from a global perspective and in terms of the 
development of China-based companies," said PharmaLex CEO DR.Thomas Dobmeyer.  

"Onboarding the China team to the PharmaLex Organization underscores our 
commitment to employing the right expertise in all our global offices.  We are 
honored to welcome the team of highly experienced China personnel and together 
develop our skills and capabilities with these valued colleagues while offering 
them career and expertise development." 

About us:
About PharmaLex <Confidence beyond compliance>:
PharmaLex is a leading provider of specialized services for the pharma, biotech 
and medtech industries. We guide you from early strategic planning activities 
and non-clinical requirements through clinical development, regulatory 
submission processes and post-approval / maintenance post-launch activities. 
Our experts use technology-enabled solutions to support you through the entire 
product lifecycle. We deliver exceptional results — going above and beyond the 
standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 3,000 employees, with 67 offices in 32 
countries and more than 1,000 satisfied clients worldwide.

Contact details:
Ms. Elizabeth Hunt; PharmaLex GmbH; Manager External Communications
elizabeth.hunt@pharmalex.com
+00 353 86 811 2319 

SOURCE: PharmaLex